SUBSCRIPTION AGREEMENTSubscription Agreement • September 20th, 2017 • Bionik Laboratories Corp. • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
This Subscription Agreement (this “Agreement”) is made as of September 1, 2017, by and among Bionik Laboratories Corp., a Delaware corporation (the “Company”), and the subscribers identified on the signature pages hereto (each, a “Subscriber” and collectively, the “Subscribers”).
ALLONGE TO COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • September 20th, 2017 • Bionik Laboratories Corp. • Orthopedic, prosthetic & surgical appliances & supplies
Allonge (this “Allonge”) to that certain Common Stock Purchase Warrant (the “Warrant”) attached hereto as Exhibit 1 from Bionik Laboratories Corp. (the “Company”), and issued to [ ]., as Holder (the “Holder”).
COMMON STOCK PURCHASE WARRANT BIONIK LABORATORIES CORP.Bionik Laboratories Corp. • September 20th, 2017 • Orthopedic, prosthetic & surgical appliances & supplies
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [____________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Pricing Date (the “Initial Exercise Date”) and on or prior to 5:30 p.m. (New York time) on the Five (5) year anniversary of the Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from BIONIK LABORATORIES CORP., a Delaware corporation (the “Company”), a maximum number of shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock equal to the Share Limit. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). The Warrant is one of a series of like common stock purchase warrants issued by the Company as of August 14, 2017, to certain of the Company’s holders of outstanding indebtedness (
